Giuseppe Cocco
Rheinfelden, AG, Switzerland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Inflammation in Heart Failure: known knowns and unknown unknowns.
Journal: Expert opinion on pharmacotherapy
Published: July 07, 2017
Anti-thromboembolic strategies in atrial fibrillation.
Journal: Cardiology journal
Published: November 02, 2015
New concepts in the therapy of atrial fibrillation.
Journal: Cardiology journal
Published: July 21, 2015
Can ivabradine reduce NT-proBNP and improve outcomes in systolic heart failure?
Journal: Cardiology journal
Published: July 05, 2015
Angina pectoris in patients without flow-limiting coronary artery disease (cardiac syndrome X). A forest of a variety of trees.
Journal: Cardiology journal
Published: April 15, 2015
Torsades de pointes induced by the concomitant use of ivabradine and azithromycin: an unexpected dangerous interaction.
Journal: Cardiovascular toxicology
Published: August 28, 2014
Assessing the benefits of natriuretic peptides-guided therapy in chronic heart failure.
Journal: Cardiology journal
Published: March 10, 2014
Comparison between ivabradine and low-dose digoxin in the therapy of diastolic heart failure with preserved left ventricular systolic function.
Journal: Clinics and practice
Published: June 05, 2013
Cardiac pathology and modern therapeutic approach in Behçet disease.
Journal: Cardiology journal
Published: April 07, 2013
Management of myocardial ischemia. Is ranolazine needed? For all or some patients with myocardial ischemia?
Journal: Expert opinion on pharmacotherapy
Published: November 06, 2012
A patient with Leiden V mutation, multiple sclerosis, psoriasis, and sicca syndrome: could celecoxib and fingolimod adversely affect the heart?
Journal: Cardiovascular toxicology
Published: April 25, 2012
Showing 1-11 of 11
Last Updated: 09/26/2026